MCRB Recommendations for the Improved Treatment of COPD
Jointly provided by:
Impact Education, LLC     Postgraduate Institute for Medicine
Supported by independent educational grants from AstraZeneca and Boehringer Ingelheim Pharmaceuticals, Inc.


Tuesday, January 12, 2016 from 1:00 PM - 3:00 PM EST

Carl Asche, PhD, MBA, MSc
Center for Outcomes Research
University of Illinois College of Medicine at Peoria
Angela Golden, DNP, FNP-C, FAANP
Family Nurse Practitioner
NP from Home, LLC
Family Nurse Practitioner
North Country Community Health Center
Nicola Hanania, MD, MS
Associate Professor
Department of Pulmonary and Critical Care
Baylor College of Medicine .
Kenneth Schaecher, MD, FACP, CPC
Medical Director

  • Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
  • Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for chronic obstructive pulmonary disease (COPD) including: physicians, pharmacists, registered nurses, and case managers
Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease which affects more than fifteen million Americans, with more than 50% of adults with low pulmonary function unaware that they have COPD. It is the third leading cause of death in the United States, responsible for greater than 130,000 deaths each year. Currently diagnosis, assessment, and therapeutic management are based almost exclusively on the severity of airflow limitation; however, each patient's comorbidities differ and many cannot be successfully managed with just a single intervention necessitating an overall care approach in order to improve treatment outcomes. As the COPD treatment landscape evolves, treatment management decision-making is becoming more complex and MCOs and other payer organizations need to appropriately and effectively design benefit that optimize both cost-efficiency and patient outcomes. This activity is aimed at improving the understanding among managed care providers of the need to establish correct diagnosis, initiate appropriate therapeutic intervention(s), recognize and treat common comorbidities, coordinate activates of a multidisciplinary COPD care team, recognize and treat exacerbations, and provide effective patient education.

The first curriculum of its kind, The Managed Care Review BoardTM (MCRBTM) is specifically designed and developed for managed care professionals. It uses a multidisciplinary, evidence-based process for decision-making that contributes to the optimization of patient outcomes to enhance managed care stakeholders' ability to compare the effects of various treatment options on clinical outcomes, perceived value, and economic implications for the entire health care system. The MCRBTM format features review of important, relevant therapeutic category information and features peer-to-peer exchange between a diverse group of managed care and clinical specialty faculty contributors. This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients with COPD.

After completing this activity, the participant should be better able to:
  • Discuss COPD guidelines and the evolving treatment landscape of COPD
  • Explain the importance of early recognition of patients at risk, accurate diagnosis of COPD, utilizing spirometry, and understanding the benefits of both non-pharmacologic disease management and pharmacologic treatment
  • Illustrate the need to diagnose and manage comorbid conditions in COPD patients
  • Employ strategies to increase coordination of care for patients with COPD among multidisciplinary care teams within the managed care setting to optimize transition of care
  • Examine differences between asthma and COPD exacerbation and review COPD exacerbation management strategies
  • Apply practical strategies to increase health plan members' knowledge of the disease and its management
  • Provide accurate and appropriate counsel as part of the managed care treatment team
  • Provide appropriate care and counsel for patients and their families
1:00 PM - 1:05 PM Introduction & Overview
1:05 PM - 1:35 PM Establishing the Correct Diagnosis of COPD in a Managed Care Setting
Nicola Hanania, MD, MS
1:35 PM - 1:55 PM Analysis of the Therapeutics and Economic Impact of COPD Therapies
Carl Asche, PhD, MBA, MSc
1:55 PM - 2:05 PM Faculty Idea Exchange
2:05 PM - 2:25 PM Optimizing Transitionary Care for Health Plan Members with COPD
Angela Golden, DNP, FNP-C, FAANP
2:25 PM - 2:45 PM Review of Practical Strategies for MCOs' to Increase Members' Knowledge of COPD and its Management
Kenneth Schaecher, MD, FACP, CPC
2:45 PM - 2:55 PM Faculty Idea Exchange
Faculty Q&A Session
2:55 PM - 3:00 PM Closing Commentary

Physician Continuing Education

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - (0809-9999-16-036-L01-P)

Type of Activity: Knowledge

Upon receipt of the completed activity evaluation form, transcript information will be available at within 4 weeks.

Nursing Continuing Education

Credit Designation
This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A statement of credit will be issued only upon receipt of a completed activity evaluation form.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up

Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

There is no fee for this educational activity

If you have any questions, please call (215) 619-8812 or email

Click here to register.